Insulin glargine/lixisenatide

Insulin glargine/lixisenatide is a combination medication used in the treatment of Type 2 diabetes. It is a combination of insulin glargine, a long-acting insulin, and lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist.

Composition

The medication is composed of two active ingredients: insulin glargine and lixisenatide. Insulin glargine is a long-acting insulin analog that helps to control blood sugar levels in individuals with diabetes. Lixisenatide is a GLP-1 receptor agonist that slows gastric emptying and increases insulin secretion.

Uses

Insulin glargine/lixisenatide is used to improve blood sugar control in adults with Type 2 diabetes. It is used when diet and exercise alone does not provide adequate blood sugar control.

Side Effects

Common side effects of insulin glargine/lixisenatide include hypoglycemia, allergic reactions, injection site reactions, and gastrointestinal problems. Severe side effects may include pancreatitis and heart failure.

Precautions

Before starting treatment with insulin glargine/lixisenatide, patients should inform their healthcare provider about all their medical conditions and medications. It is not recommended for use in patients with Type 1 diabetes or for the treatment of diabetic ketoacidosis.

Interactions

Insulin glargine/lixisenatide may interact with other medications, which can affect how it works or increase the risk of serious side effects. Patients should inform their healthcare provider about all the medications they are currently taking.

Dosage

The dosage of insulin glargine/lixisenatide is individualized based on the patient's blood sugar control, response to therapy, and other medical conditions.

Storage

Insulin glargine/lixisenatide should be stored in the refrigerator, away from light and heat. It should not be frozen.

See Also

• Insulin glargine
• Lixisenatide
• Type 2 diabetes

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia